Physician profile
Roland Stanley Kent
NPI 1619942927
$1,147,188.21
in general payments reported to CMS, 2019-2025
34 companies · $241K in 2025
The $241K reported for 2025 was more than what 96% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $88K · 2021: $127K · 2022: $189K · 2023: $249K · 2024: $229K · 2025: $241K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $533K · Travel and Lodging: $77K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $75K · Royalty Or License: $22K · Food and Beverage: $13K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $532,671.46 |
| Travel and Lodging | $76,557.79 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75,000.00 |
| Royalty Or License | $22,140.81 |
| Food and Beverage | $12,845.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $722,148.90 | 2019-2025 | Excelsiusgps Robotic Navigation System, Excelsius Gps, Elsa |
| Si-Bone, INC. | $244,758.06 | 2019-2025 | |
| Carlsmed, INC. | $101,690.01 | 2021-2025 | Aprevo |
| Orthofundamentals, LLC | $22,140.81 | 2024-2025 | Trellis Si Joint Fusion System |
| Cerapedics INC. | $13,038.74 | 2021-2025 | I-Factor Peptide Enhanced Bone Graft |
| Premia Spine, Ltd. | $11,828.96 | 2025 | Tops |
| Kuros Biosciences USA, INC | $9,035.43 | 2025 | Magnetos |
| Surgalign Spine Technologies, INC. | $8,838.85 | 2019-2020 | |
| Depuy Synthes Products, INC. | $7,691.74 | 2019 | |
| Medical Device Business Services, INC. | $2,257.67 | 2020-2025 | Velys |
| Nuvasive, INC. | $1,209.80 | 2019 | |
| Depuy Synthes Sales INC. | $799.01 | 2019-2024 | Teligen, Viper |
| Nevro Corp. | $319.06 | 2019-2024 | Senza |
| Bioventus LLC | $208.76 | 2019-2023 | Bonescalpel |
| Alphatec Spine, INC | $150.00 | 2024 | Other - Miscellaneous |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainlab, INC. | $142.42 | 2021 | |
| Spineart USA INC | $136.44 | 2021 | |
| Orthofix Medical, INC. | $133.60 | 2025 | Miscellaneous |
| Ossdsign USA Incorporated | $116.06 | 2023-2024 | |
| Integrity Implants INC. | $77.40 | 2022 | |
| Boston Scientific Corporation | $62.99 | 2019-2021 | |
| Spinal Elements, INC. | $56.66 | 2025 | |
| Nalu Medical, INC. | $52.50 | 2021 | |
| Providence Medical Technology, INC. | $44.78 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $38.41 | 2021 | |
| Seaspine Orthopedics Corporation | $38.29 | 2022 | |
| Stryker Corporation | $28.58 | 2019-2020 | |
| Osteocentric Technologies, INC. | $27.45 | 2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Stimwave Technologies Incorporated | $23.21 | 2021 | |
| Daiichi Sankyo INC. | $22.64 | 2019 | |
| Indivior INC. | $20.29 | 2019 | |
| Abbott Laboratories | $19.58 | 2021 | |
| Merck Sharp & Dohme LLC | $19.27 | 2023 | Keytruda |
| Merit Medical Systems INC | $11.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roland Kent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.